Group B Streptococcal Disease: Interim Prevention at 50 Years and Counting

Affiliations

¹ Section of Infectious Diseases, Department of Pediatrics, Baylor College of Medicine.
² Division of Infectious Diseases, Department of Pediatrics, McGovern Medical School, The University of Texas Health Science Center at Houston.

Comment

Morven S Edwards et al. Clin Infect Dis. 2020.

. 2020 Jun 10;70(12):2580-2581.

doi: 10.1093/cid/ciz738.

¹ Section of Infectious Diseases, Department of Pediatrics, Baylor College of Medicine.
² Division of Infectious Diseases, Department of Pediatrics, McGovern Medical School, The University of Texas Health Science Center at Houston.

No abstract available

Keywords: Group B Streptococcus; prevention; vaccine.

Comment on

Safety and Immunogenicity of a Second Dose of an Investigational Maternal Trivalent Group B Streptococcus Vaccine in Nonpregnant Women 4-6 Years After a First Dose: Results From a Phase 2 Trial.
Leroux-Roels G, Bebia Z, Maes C, Aerssens A, De Boever F, Grassano L, Buffi G, Margarit I, Karsten A, Cho S, Slobod K, Corsaro B, Henry O. Leroux-Roels G, et al. Clin Infect Dis. 2020 Jun 10;70(12):2570-2579. doi: 10.1093/cid/ciz737. Clin Infect Dis. 2020. PMID: 31394574 Free PMC article. Clinical Trial.